文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

局部晚期宫颈癌小于全子宫照射可维持局部区域控制并降低肠道受量

Less Than Whole Uterus Irradiation for Locally Advanced Cervical Cancer Maintains Locoregional Control and Decreases Radiation Dose to Bowel.
PubMed 文献 · Pract Radiat Oncol · 2018-11-02

本机构标准对53例IB-IVB期宫颈癌行图像引导调强放疗和近距离放疗,靶区不含全子宫。中位随访44个月,无孤立局部复发,2年局部区域失败率10.9%。PET GTV与任何失败风险升高相关(P=0.049;95%CI 1.000-1.018)。子宫纳入PTV<90%者较≥90%者肠道V40(P=0.049)和D200cc(P=0.006)显著降低。

要点

  • 本机构标准对局部晚期宫颈癌行小于全子宫照射,中位随访44个月无孤立局部复发。
  • 2年局部区域失败率为10.9%,PET GTV与任何失败风险升高相关(P=0.049)。
  • 子宫纳入PTV<90%者较≥90%者肠道V40和D200cc显著降低。

核心结论

  • 局部晚期宫颈癌小于全子宫照射不损害局部区域控制,并降低肠道V40和D200cc。
  • 需进一步研究评估肠道剂量降低是否转化为临床显著的肠道毒性减少,以及是否应修改推荐的根治性宫颈调强放疗体积。

研究设计与样本

  • 回顾性综述53例IB至IVB期宫颈癌患者,接受图像引导调强放疗和近距离放疗,按本机构标准临床靶区不含全子宫。

主要发现

  • 子宫纳入PTV的中位比例为66%。
  • 中位随访44个月,无患者发生孤立局部复发,2年局部区域失败率为10.9%。
  • PET GTV与任何失败风险升高显著相关(P=0.049;95%CI 1.000-1.018)。
  • 子宫纳入PTV≥90%者(n=12)与<90%者(n=41)相比,后者肠道V40显著更低(P=0.049),D200cc显著更低(P=0.006)。

临床怎么用

  • 原文结论认为小于全子宫照射不损害局部区域控制并降低肠道剂量,同时指出需进一步研究评估肠道毒性转化及靶区体积修改。

局限性

  • 需进一步研究评估肠道剂量降低是否转化为临床显著的肠道毒性减少及是否修改推荐靶区体积。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to evaluate whether our institutional standard of less-than-whole-uterus irradiation affects locoregional control in patients with locally advanced cervical cancer. METHODS AND MATERIALS: We retrospectively reviewed 53 patients with stage IB to IVB cervical carcinoma who were treated with image guided intensity modulated radiation therapy and brachytherapy. The entire uterus was not included in the clinical target volume, as per our institutional standard. Dosimetric parameters were obtained, including positron emission tomography gross tumor volume (GTV), uterus volume excluding GTV, proportion of uterus included in the planning target volume (PTV; percentage), volume of overlap between uterus and prescription dose (cm3), minimum and mean dose to the uterus, and bowel V40 and D200cc. Local, regional, and distant failure and death were recorded. RESULTS: The median proportion of the uterus included in the PTV was 66%. With a median follow-up of 44 months, no patient experienced isolated local recurrence, and 2-year locoregional failure was 10.9%. Positron emission tomography GTV correlated significantly with increased chance of any failure (P = .049; 95% confidence interval, 1.000-1.018). Compared with patients who had ≥90% of the uterus included in the PTV (n = 12), patients who had <90% (n = 41) of the uterus included in the PTV had significantly lower bowel V40 (P = .049) and D200cc (P = .006). CONCLUSIONS: Less-than-whole-uterus irradiation for locally advanced cervical cancer does not compromise locoregional control and reduces bowel V40 and D200cc. Further investigation is required to evaluate whether this reduction in bowel dose translates to a clinically significant reduction in bowel toxicity and whether modifications should be made to the recommended definitive cervix intensity modulated radiation therapy volumes.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Kozak MM, Koenig JL, von Eyben R, et al. Less Than Whole Uterus Irradiation for Locally Advanced Cervical Cancer Maintains Locoregional Control and Decreases Radiation Dose to Bowel. Pract Radiat Oncol. 2018. PMID: 30395974. doi:10.1016/j.prro.2018.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。